Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society-Reference-Cited by-同舟云学术

Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society

Published:2019 Issue:12 Volume:59 Page:449-491
ISSN:0470-8105
Container-title:Neurologia medico-chirurgica
language:en
Short-container-title:Neurol. Med. Chir.(Tokyo)

Author:

TOYODA Kazunori¹,KOGA Masatoshi¹,IGUCHI Yasuyuki²,ITABASHI Ryo³,INOUE Manabu⁴,OKADA Yasushi⁵,OGASAWARA Kuniaki⁶,TSUJINO Akira⁷,HASEGAWA Yasuhiro⁸,HATANO Taketo⁹,YAMAGAMI Hiroshi¹⁰,IWAMA Toru¹¹,SHIOKAWA Yoshiaki¹²,TERAYAMA Yasuo¹³,MINEMATSU Kazuo¹⁴

Affiliation:

1. Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center

2. Department of Neurology, The Jikei University School of Medicine

3. Department of Stroke Neurology, Kohnan Hospital

4. Division of Stroke Care Unit, National Cerebral and Cardiovascular Center

5. Department of Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Center

6. Department of Neurosurgery, Iwate Medical University

7. Department of Neurology and Strokology, Nagasaki University Hospital

8. Department of Neurology, St. Marianna University School of Medicine

9. Department of Neurosurgery, Kokura Memorial Hospital

10. Department of Stroke Neurology, National Hospital Organization Osaka National Hospital

11. Department of Neurosurgery, Gifu University School of Medicine

12. Department of Neurosurgery, Kyorin University

13. Neurological Institute, Shonan Keiiku Hospital

14. Headquarters of the Iseikai Medical Corporation

Publisher

Japan Neurosurgical Society

Subject

Clinical Neurology,Surgery

Link

https://www.jstage.jst.go.jp/article/nmc/59/12/59_st.2019-0177/_pdf

Reference173 articles.

1. 1) Yamaguchi T, Mori E, Minematsu K, et al.: Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 37: 1810–1815, 2006

2. 2) Guideline Committee of the Japan Stroke Society for the intravenous rt-PA (alteplase) in acute ischemic stroke. Jpn J Stroke 27: 327–354, 2005 (Japanese)

3. 3) Minematsu K, Toyoda K, Hirano T, et al.: Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society. J Stroke Cerebrovasc Dis 22: 571–600, 2013

4. 4) Guideline Committee of the Japan Stroke Society for the intravenous rt-PA (alteplase) in acute ischemic stroke. Guidelines for intravenous application of rt-PA (alteplase), October 2012, partly revised in September 2016. Jpn J Stroke 39: 43–86, 2017 (Japanese)

5. 5) Guideline Committee of the Japan Stroke Society, Japan Neurosurgical Society, and Japanese Society for Endovascular Therapy. Guidelines for Mechanical Thrombectomy, the third edition, March 2018. Jpn J Stroke 40: 285–309, 2018 (Japanese)

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selenium’s Role in Neuroprotection Against Stroke-Induced Inflammation;Cureus;2024-01-13

2. Improvement of Functional Outcomes in Patients with Stroke who Received Alteplase for Over 15 Years: Japan Stroke Data Bank;Journal of Atherosclerosis and Thrombosis;2024-01-01

3. A Single-Center Experience of Mechanical Thrombectomy for Cancer-Associated Ischemic Stroke;Journal of Neuroendovascular Therapy;2024

4. “The microcatheter contrast injection technique”: A novel technique to detect the proximal end of a thrombus in mechanical thrombectomy;The Neuroradiology Journal;2023-12-27

5. Detrimental effect of anemia after mechanical thrombectomy on functional outcome in patients with ischemic stroke;Frontiers in Neurology;2023-12-19